ClearPoint Neuro (CLPT) Preferred Shares (2011)
ClearPoint Neuro (CLPT) reported Preferred Shares of $8.0 million for Q4 2011.
ClearPoint Neuro (CLPT) Preferred Shares (2011) Analysis & Trends
ClearPoint Neuro (CLPT) has 1 years of Preferred Shares data on file, last reported at $8.0 million in Q4 2011.
- For the quarter ending Q4 2011, Preferred Shares changed N/A year-over-year to $8.0 million; the trailing twelve-month figure through Dec 2011 stood at $8.0 million (changed N/A YoY), and the FY2011 full-year result was $8.0 million, changed N/A from the prior year.
- Preferred Shares was little changed at $8.0 million in Q4 2011.
- In the past five years, Preferred Shares ranged from a high of $8.0 million in Q4 2011 to a low of $8.0 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 7.97 Mn |